141 related articles for article (PubMed ID: 3373744)
1. [Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; administration of synergistic drugs for protective factors in peptic ulcer--criteria of drug selection according to clinical symptoms and administration methods].
Fukuchi S
Nihon Rinsho; 1988 Jan; 46(1):119-23. PubMed ID: 3373744
[No Abstract] [Full Text] [Related]
2. [Comparative studies on recurrence and relapse rate in peptic ulcer treated with various types of anti-ulcer agent; synergistic drugs for protective factors in peptic ulcer].
Miyake T
Nihon Rinsho; 1988 Jan; 46(1):79-83. PubMed ID: 3373760
[No Abstract] [Full Text] [Related]
3. [Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; combination therapy of inhibitors of attacking factors and synergistic drugs for protective factors in peptic ulcer--selection of drug combinations and clinical efficacy].
Sakai M
Nihon Rinsho; 1988 Jan; 46(1):124-32. PubMed ID: 3373745
[No Abstract] [Full Text] [Related]
4. [Treatment of peptic ulcer with sucralfate].
Brailski Kh; Mendizova A; Matov V; Dimitrov B
Klin Med (Mosk); 1991 Aug; 69(8):78-80. PubMed ID: 1791718
[TBL] [Abstract][Full Text] [Related]
5. Role of protective drugs in the prevention of ulcer relapse.
Ota S; Terano A
J Gastroenterol; 1994 Jul; 29 Suppl 7():139-40. PubMed ID: 7921147
[TBL] [Abstract][Full Text] [Related]
6. Effect of p-hydroxyphenyl-propionic ester of tranexamic acid hydrochloride (Cetraxate) on peptic ulcer. Multi-center clinical study.
Ishimori A; Yamagata S; Taima T
Arzneimittelforschung; 1979; 29(10):1625-32. PubMed ID: 391240
[TBL] [Abstract][Full Text] [Related]
7. [Prevention of stress ulcer with topically active drugs: an effective and sensible therapeutic approach? Arguments pro].
Gugler R
Z Gastroenterol; 1991 Jan; 29 Suppl 1():16-8; discussion 21-2. PubMed ID: 1683733
[No Abstract] [Full Text] [Related]
8. [Prevention of stress ulcer with topically acting drugs: an effective and sensible therapeutic approach? Arguments contra].
Janisch HD
Z Gastroenterol; 1991 Jan; 29 Suppl 1():19-20; discussion 21-2. PubMed ID: 1962496
[No Abstract] [Full Text] [Related]
9. [Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; problems on standardization of the appropriate time for the withdrawal of anti-ulcer agents].
Takemoto T; Yanai H
Nihon Rinsho; 1988 Jan; 46(1):133-9. PubMed ID: 3373746
[No Abstract] [Full Text] [Related]
10. Effect of sucralfate on peptic ulcer recurrence: a controlled double-blind multicenter study.
Classen M; Bethge H; Brunner G; Dirr B; Frotz H; Gabor M; Gail H; Grabner R; Hagenmüller F; Heinkel K
Scand J Gastroenterol Suppl; 1983; 83():61-8. PubMed ID: 6356323
[TBL] [Abstract][Full Text] [Related]
11. A new screening method for anti-ulcer agents: psychological stress produced by intraspecies emotional communication.
Ichimaru Y; Gomita Y
Pharmacology; 1987; 34(2-3):176-80. PubMed ID: 3588656
[TBL] [Abstract][Full Text] [Related]
12. Sucralfate effervescent tablet: treatment of peptic ulcer disease and change in serum aluminium concentration.
Schütze K; Hentschel E; Happonen P; Akkila J
Hepatogastroenterology; 1995 Jul; 42(3):240-5. PubMed ID: 7590572
[TBL] [Abstract][Full Text] [Related]
13. Peptic ulcers in the elderly: unique features and management.
Freston MS; Freston JW
Geriatrics; 1990 Jan; 45(1):39-42, 45. PubMed ID: 2403956
[TBL] [Abstract][Full Text] [Related]
14. [Recent developments in synergistic drugs for protective factors in peptic ulcer--clinical efficacy and problems; mucosal blood-flow improving agents].
Shimakura S; Fukutomi H
Nihon Rinsho; 1988 Jan; 46(1):55-63. PubMed ID: 3373758
[No Abstract] [Full Text] [Related]
15. Maintenance treatment of patients with healed peptic ulcer with sucralfate, placebo and cimetidine.
Libeskind M
Scand J Gastroenterol Suppl; 1983; 83():69-70. PubMed ID: 6356324
[TBL] [Abstract][Full Text] [Related]
16. Topically active drugs in the treatment of peptic ulcers. Focus on colloidal bismuth subcitrate and sucralfate.
Bianchi Porro G; Parente F
J Clin Gastroenterol; 1992 Apr; 14(3):192-8. PubMed ID: 1348753
[TBL] [Abstract][Full Text] [Related]
17. [Antirecurrence treatment of peptic ulcer].
Papikian MKh; Vaĭstukh SI; Kulabukhov VG
Ter Arkh; 1980; 52(7):118-21. PubMed ID: 6996196
[No Abstract] [Full Text] [Related]
18. [Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; intermittent and long-term administration].
Sakai H; Oka H; Sakaguchi M
Nihon Rinsho; 1988 Jan; 46(1):114-8. PubMed ID: 2897481
[No Abstract] [Full Text] [Related]
19. [Prevention of ulcer disease].
Loizeau E
Schweiz Med Wochenschr; 1986 Oct; 116(40):1371-4. PubMed ID: 2877491
[TBL] [Abstract][Full Text] [Related]
20. [Current aspects of course treatment and secondary prevention of peptic ulcer].
Ryss ES
Klin Med (Mosk); 1990 Apr; 68(4):134-42. PubMed ID: 1973467
[No Abstract] [Full Text] [Related]
[Next] [New Search]
